Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncol 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106

Article  PubMed  PubMed Central  CAS  Google Scholar 

American Association of Neurological Surgeons (2023) Glioblastoma Multiforme. https://www.aans.org/en/Patients/Neurosurgical-Conditions-and-Treatments/Glioblastoma-Multiforme (accessed 17 October 2023)

Waddington CH (2016) An introduction to modern genetics. Routledge

Zhang Y, Cruickshanks N, Pahuski M, Yuan F, Dutta A, Schiff D, Abounader R (2017) Noncoding RNAs in glioblastoma. Exon Publications 95–130. https://doi.org/10.15586/codon.glioblastoma.2017.ch6

Klughammer J, Kiesel B, Roetzer T, Fortelny N, Nemc A, Nenning KH, Bock C (2018) The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space. Nat Med 24(10):1611–1624. https://doi.org/10.1038/s41591-018-0156-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bernstein BE, Stamatoyannopoulos JA, Costello JF, Ren B, Milosavljevic A, Meissner A, Thomson JA (2010) The NIH roadmap epigenomics mapping consortium. Nat Biotechnol 28(10):1045–1048. https://doi.org/10.1038/nbt1010-1045

Article  PubMed  PubMed Central  CAS  Google Scholar 

Alanazi SHS, Khan MF, Alazami AM, Baabbad A, Wadaan MA (2024) Calotropis procera: a double edged sword against glioblastoma, inhibiting glioblastoma cell line growth by targeting histone deacetylases (HDAC) and angiogenesis. https://doi.org/10.1016/j.heliyon.2024.e24406. Heliyon

Ahuja N, Sharma AR, Baylin SB (2016) Epigenetic therapeutics: a new weapon in the war against cancer. Annu Rev Med 67:73–89. https://doi.org/10.1146/annurev-med-111314-035900

Article  PubMed  PubMed Central  CAS  Google Scholar 

Azad N, Zahnow CA, Rudin CM, Baylin SB (2013) The future of epigenetic therapy in solid tumours—lessons from the past. Nat Rev Clin Oncol 10(5):256–266. https://doi.org/10.1038/nrclinonc.2013.42

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zang L, Kondengaden SM, Che F, Wang L, Heng X (2018) Potential epigenetic-based therapeutic targets for glioma. Front Mol Neurosci 11:408. https://doi.org/10.3389/fnmol.2018.00408

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim YZ (2014) Altered histone modifications in gliomas. Brain Tumor Res Treat 2:7–21. https://doi.org/10.14791/btrt.2014.2.1.7

Article  PubMed  PubMed Central  Google Scholar 

Bruns AF, Rippaus N, Droop A, Al-Jabri M, Care M, Jenkinson M, Stead LF (2019) Chromatin remodelling to facilitate treatment resistance in glioblastoma. Neuro-Oncol 21(Suppl 4):iv7. https://doi.org/10.1093/neuonc/noz167.027

Article  PubMed Central  Google Scholar 

Rasras S, Zibara K, Vosughi T, Zayeri Z (2018) Genetics and epigenetics of Glioblastoma: Therapeutic challenges. Clin Cancer Investig J 7(2). https://doi.org/10.4103/ccij.ccij_82_17

Li J, Zhu Y, Wang H, Ji X (2018) Targeting long noncoding RNA in glioma: a pathway perspective. Mol Ther Nucleic Acids 13:431–441. https://doi.org/10.1016/j.omtn.2018.09.023

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, Huang S (2017) m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell 31(4):591–606. https://doi.org/10.1016/j.ccell.2017.02.013

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dong Z, Cui H (2020) The emerging roles of RNA modifications in Glioblastoma. Cancers 12:736. https://doi.org/10.3390/cancers12030736

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhang C, Liang S, Zhang H, Wang R, Qiao H (2024) Epigenetic regulation of mRNA mediates the phenotypic plasticity of cancer cells during metastasis and therapeutic resistance (review). Oncol Rep 51(2):28. https://doi.org/10.3892/or.2023.8687

Article  PubMed  CAS  Google Scholar 

Christoph S, Alicia S, Fritz T, Vanessa T, Ralf K, Jin KY (2023) Linsler Stefan, and Oertel Joachim. The intra-tumoral heterogeneity in glioblastoma—a limitation for prognostic value of epigenetic markers? Acta Neurochir 165(6):1635–1644

Article  PubMed  Google Scholar 

Métais A, Tauziède-Espariat A, Garcia J, Appay R, Uro-Coste E, Meyronet D, Biopathology RENOCLIP-LOC network Rousseau A. Godfraind C. Gauchotte G. Mokhtari K. Bielle F. Escande F. Fina F. (2023) Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3:: TACC3 fusion. Acta Neuropathol Commun 11(1):14

Article  PubMed  PubMed Central  Google Scholar 

Colella B, Faienza F, Di Bartolomeo S (2019) EMT regulation by autophagy: a new perspective in glioblastoma biology. Cancers 11(3):312

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zhou D, Alver BM, Li S, Hlady RA, Thompson JJ, Schroeder MA, Lee JH, Qiu J, Schwartz PH, Sarkaria JN, Robertson KD (2018) Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues. Genome Biol 27(1):43. https://doi.org/10.1186/s13059-018-1420-6

Article  CAS  Google Scholar 

Postwala H, Shah Y, Parekh PS, Chorawala MR (2023) Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways. Med Oncol 40(11):334

Article  PubMed  Google Scholar 

Huang T (ed) (2023) Epigenetics-Regulation and New perspectives: Regulation and New perspectives. BoD–Books on Demand

Wu R, Yun Q, Zhang J, Bao J (2019) Downregulation of KLF13 through DNMT1-mediated hypermethylation promotes glioma cell proliferation and invasion. Onco Targets Ther 12:1509. https://doi.org/10.2147/OTT.S188270

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brandes AA, Franceschi E, Paccapelo A, Tallini G, De Biase D, Ghimenton C, Ermani M (2017) Role of MGMT methylation status at time of diagnosis and recurrence for patients with glioblastoma: clinical implications. Oncologist 22(4):432–437. https://doi.org/10.1634/theoncologist.2016-0254

Article  PubMed  PubMed Central  CAS  Google Scholar 

Wu Q, Berglund AE, Wang D, MacAulay RJ, Mulé JJ, Etame AB (2019) Paradoxical epigenetic regulation of XAF1 mediates plasticity towards adaptive resistance evolution in MGMT-methylated glioblastoma. Sci Rep 9(1):14072. https://doi.org/10.1038/s41598-019-50489-2

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dejaegher J, Solie L, Hunin Z, Sciot R, Capper D, Siewert C, De Vleeschouwer S (2021) DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival. Neuro-oncol 23(2):240–250. https://doi.org/10.1093/neuonc/noaa247

Article  PubMed  CAS  Google Scholar 

Flavahan, W. A., Drier, Y., Liau, B. B., Gillespie, S. M., Venteicher, A. S., Stemmer-Rachamimov,A. O.,… Bernstein, B. E. (2016). Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature. 529(7584):110–114. https://doi.org/10.1038/nature16490

Ma X, Shang F, Zhu W, Lin Q (2017) CXCR4 expression varies significantly among different subtypes of glioblastoma multiforme (GBM) and its low expression or hypermethylation might predict favorable overall survival. Expert Rev Neurother 17(9):941–946. https://doi.org/10.1080/14737175.2017.1351299

Article  PubMed  CAS  Google Scholar 

Xia, X., Cao, F., Yuan, X., Zhang, Q., Chen, W., Yu, Y.,… Yao, S. (2019). Low expression or hypermethylation of PLK2 might predict favorable prognosis for patients with glioblastoma multiforme. PeerJ. 7:e7974. https://doi.org/10.7717/peerj.7974

Cao F, Xia X, Fan Y, Liu Q, Song J, Zhang Q, Yao S (2021) Knocking down of Polo-like kinase 2 inhibits cell proliferation and induced cell apoptosis in human glioma cells. Life Sci 270:119084. https://doi.org/10.1016/j.lfs.2021.119084

Article  PubMed  CAS  Google Scholar 

Zhang B, Gu X, Han X, Gao Q, Liu J, Guo T, Gao D (2020) Crosstalk between DNA methylation and histone acetylation triggers GDNF high transcription in glioblastoma cells. Clin Epigenetics 12:1–16. https://doi.org/10.1186/s13148-020-00835-3

Article  CAS  Google Scholar 

Lu C, Wei Y, Wang X, Zhang Z, Yin J, Li W, You Y (2020) DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma. Mol Cancer 19(1–19). https://doi.org/10.1186/s12943-020-1137-5

Haase S, Nuñez FM, Gauss JC, Thompson S, Brumley E, Lowenstein P, Castro MG (2020) Hemispherical pediatric high-grade glioma: molecular basis and therapeutic opportunities. Int J Mol Sci 21(24):9654. https://doi.org/10.3390/ijms21249654